U.S. transgender billionaire Martine Rothblatt sells $5.5 million in United Therapeutics stock
Martine Rothblatt, the founder and chief executive of drugmaker United Therapeutics, sold about $5.5 million of stock as the shares climbed toward a 52-week high.